The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II randomized, placebo-controlled trial of phytotherapeutic product Catuama for breast cancer women undergoing adjuvant radiation therapy.
Felipe Melo Cruz
No relevant relationships to disclose
Daniel de Iracema Gomes Cubero
No relevant relationships to disclose
Patricia Xavier Santi
No relevant relationships to disclose
Luciana Garcia Landeiro
No relevant relationships to disclose
Andressa Sayuri Tamashiro
No relevant relationships to disclose
Larisse Soares Ribeiro
No relevant relationships to disclose
Auro Del Giglio
No relevant relationships to disclose